Predictors of Clinical Hematological Toxicities under Radiotherapy in Patients with Cervical Cancer—A Risk Analysis
This study shows the existence of clinical and blood predictors of hematological adverse reactions in cervical cancer patients. Thus, patients who are in a precarious clinical situation, with low hematological values (but not yet abnormal), should be monitored during days 29-35 after the initiation of RT, especially if they are obese or over 53 years of age.
Authors
- Laurenţia Galeş (ORCID: https://orcid.org/0000-0002-0414-1607)
- Radu-Valeriu Toma (ORCID: https://orcid.org/0000-0002-9785-7064)
- Șerban Andrei Marinescu
- Oana Trifănescu (ORCID: https://orcid.org/0000-0001-9566-7067)
- Liviu Bîlteanu
- Antonia Ruxandra Folea
- Rodica Maricela Anghel
- Adrian Sima
Institutions
- Carol Davila University of Medicine and Pharmacy (RO)
- University of Agronomic Sciences and Veterinary Medicine of Bucharest (RO)
- National Institute for Research and Development in Microtechnologies (RO)
- Institutul Oncologic Bucuresti (RO)
Publication Details
- Journal
- Cancers
- Published
- 2024-08-30
- DOI
- https://doi.org/10.3390/cancers16173032
- Citations
- 6
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.50